Department of Medicine, Division of Endocrinology, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.
Diabetes Res Clin Pract. 2010 Oct;90(1):e19-21. doi: 10.1016/j.diabres.2010.07.008. Epub 2010 Aug 16.
Recent studies indicate that not all diabetic subjects benefit from aspirin therapy. Our objective is to characterize diabetic subjects with aspirin resistance using urine thromboxane, and VerifyNow measures. Our results suggest that cardiovascular disease, microalbuminuria, poor diabetes control, and increased waist circumference help identify aspirin resistance in diabetes.
最近的研究表明,并非所有糖尿病患者都能从阿司匹林治疗中获益。我们的目的是使用尿血栓烷和 VerifyNow 测量来描述阿司匹林抵抗的糖尿病患者。我们的研究结果表明,心血管疾病、微量白蛋白尿、糖尿病控制不佳和腰围增加有助于识别糖尿病患者的阿司匹林抵抗。